254 related articles for article (PubMed ID: 3424264)
1. Combined versus single antituberculosis drugs on the in vitro sensitivity patterns of non-tuberculous mycobacteria.
Banks J; Jenkins PA
Thorax; 1987 Nov; 42(11):838-42. PubMed ID: 3424264
[TBL] [Abstract][Full Text] [Related]
2. In vitro synergistic activity of ethambutol, isoniazid, kanamycin, rifampin, and streptomycin against Mycobacterium avium-intracellulare complex.
Zimmer BL; DeYoung DR; Roberts GD
Antimicrob Agents Chemother; 1982 Jul; 22(1):148-50. PubMed ID: 7125626
[TBL] [Abstract][Full Text] [Related]
3. First randomised trial of treatments for pulmonary disease caused by M avium intracellulare, M malmoense, and M xenopi in HIV negative patients: rifampicin, ethambutol and isoniazid versus rifampicin and ethambutol.
Research Committee of the British Thoracic Society
Thorax; 2001 Mar; 56(3):167-72. PubMed ID: 11182006
[TBL] [Abstract][Full Text] [Related]
4. Synergistic activity of rifampicin and ethambutol against slow-growing nontuberculous mycobacteria is currently of questionable clinical significance.
van Ingen J; Hoefsloot W; Mouton JW; Boeree MJ; van Soolingen D
Int J Antimicrob Agents; 2013 Jul; 42(1):80-2. PubMed ID: 23664674
[TBL] [Abstract][Full Text] [Related]
5. Bacteriostatic and bactericidal activity of antituberculosis drugs against Mycobacterium tuberculosis, Mycobacterium avium-Mycobacterium intracellulare complex and Mycobacterium kansasii in different growth phases.
Yamori S; Ichiyama S; Shimokata K; Tsukamura M
Microbiol Immunol; 1992; 36(4):361-8. PubMed ID: 1406364
[TBL] [Abstract][Full Text] [Related]
6. Drug susceptibility testing of slowly growing non-tuberculous mycobacteria using slomyco test-system.
Litvinov V; Makarova M; Galkina K; Khachaturiants E; Krasnova M; Guntupova L; Safonova S
PLoS One; 2018; 13(9):e0203108. PubMed ID: 30222736
[TBL] [Abstract][Full Text] [Related]
7. Synergistic effect of rifampin, streptomycin, ethionamide, and ethambutol on Mycobacterium intracellulare.
Heifets LB
Am Rev Respir Dis; 1982 Jan; 125(1):43-8. PubMed ID: 7065508
[TBL] [Abstract][Full Text] [Related]
8. Sensitivity of opportunist mycobacteria to rifampicin and ethambutol.
Yates MD; Collins CH
Tubercle; 1981 Jun; 62(2):117-21. PubMed ID: 7303160
[TBL] [Abstract][Full Text] [Related]
9. Synergistic effects of antimycobacterial drug combinations on Mycobacterium avium complex determined radiometrically in liquid medium.
Hoffner SE; Svenson SB; Källenius G
Eur J Clin Microbiol; 1987 Oct; 6(5):530-5. PubMed ID: 3436314
[TBL] [Abstract][Full Text] [Related]
10. Drug Susceptibility of Non-tuberculous Strains of
Ledwoń A; Napiórkowska A; Augustynowicz-Kopeć E; Szeleszczuk P
Pol J Microbiol; 2018; 67(4):487-492. PubMed ID: 30550235
[TBL] [Abstract][Full Text] [Related]
11. Combined vs. single-drug studies of susceptibilities of Mycobacterium kansasii to isoniazid, streptomycin, and ethambutol.
Tsang AY; Bentz RR; Schork MA; Sodeman TM
Am J Clin Pathol; 1978 Nov; 70(5):816-20. PubMed ID: 717288
[TBL] [Abstract][Full Text] [Related]
12. In vitro drug sensitivity of M. avium-intracellulare complex in the presence and absence of dimethyl sulphoxide.
Nash DR; Steingrube VA
Microbios; 1982; 35(140):71-8. PubMed ID: 7162431
[TBL] [Abstract][Full Text] [Related]
13. Susceptibility testing of slowly growing mycobacteria by a microdilution MIC method with 7H9 broth.
Wallace RJ; Nash DR; Steele LC; Steingrube V
J Clin Microbiol; 1986 Dec; 24(6):976-81. PubMed ID: 3097069
[TBL] [Abstract][Full Text] [Related]
14. [Distribution and drug resistance of nontuberculous
Zhang J; Su JR; Ding BC; Liu JW; Yi JL; Yang XY; Wang NH; Wang SM
Zhonghua Jie He He Hu Xi Za Zhi; 2017 Mar; 40(3):210-214. PubMed ID: 28297817
[No Abstract] [Full Text] [Related]
15. In vitro and in vivo susceptibility of atypical mycobacteria to various drugs.
Kuze F; Kurasawa T; Bando K; Lee Y; Maekawa N
Rev Infect Dis; 1981; 3(5):885-97. PubMed ID: 7339820
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation of clinical efficacy of isoniazid and ethambutol in the treatment of nontuberculous mycobacteriosis based on in vitro susceptibility testing].
Tsukamura M
Kekkaku; 1989 Aug; 64(8):511-8. PubMed ID: 2811008
[TBL] [Abstract][Full Text] [Related]
17. Differences in drug susceptibility pattern between Mycobacterium avium and Mycobacterium intracellulare isolated in respiratory specimens.
Cho EH; Huh HJ; Song DJ; Moon SM; Lee SH; Shin SY; Kim CK; Ki CS; Koh WJ; Lee NY
J Infect Chemother; 2018 Apr; 24(4):315-318. PubMed ID: 29223615
[TBL] [Abstract][Full Text] [Related]
18. Potentiation of the effects of chlorhexidine diacetate and cetylpyridinium chloride on mycobacteria by ethambutol.
Broadley SJ; Jenkins PA; Furr JR; Russell AD
J Med Microbiol; 1995 Dec; 43(6):458-60. PubMed ID: 7473681
[TBL] [Abstract][Full Text] [Related]
19. Two groups of Mycobacterium avium complex strains determined according to the susceptibility to rifampicin and ansamycin.
Tsukamura M
Microbiol Immunol; 1987; 31(7):615-23. PubMed ID: 3125413
[TBL] [Abstract][Full Text] [Related]
20. [Sensitivity tests of mycobacteria to INH, SM, EMB and RMP in a semi-liquid serum-sauton-agar (author's transl)].
Neubert R
Z Erkr Atmungsorgane; 1976; 144(1):63-8. PubMed ID: 823718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
